Trial Profile
Open Label, Randomized, Three-way Crossover Study to Assess the Safety and the Pharmacokinetics of Sublingual Flumazenil (CRLS035) in Healthy Adults
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Feb 2016
Price :
$35
*
At a glance
- Drugs Flumazenil (Primary) ; Flumazenil (Primary)
- Indications Insomnia
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Coeruleus
- 10 Aug 2012 New trial record